The Evaluation of Bone Marrow Suppression and Secondary Malignancy Risk after Radioiodine Treatment in Patients with Thyroid Cancer after 10 Years Follow Up

Toplutas K., Sager S., Besli R. U., Asa S., Khosroshahi S., Sayman H., ...More

32nd Annual Congress of the European-Association-of-Nuclear-Medicine (EANM), Barcelona, Spain, 12 - 16 October 2019, vol.46 identifier

  • Publication Type: Conference Paper / Summary Text
  • Volume: 46
  • City: Barcelona
  • Country: Spain
  • Istanbul University Affiliated: Yes